Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:624 (11 September), doi:10.1136/bmj.329.7466.624-a
| The first 150 words of the full text of this article appear below. |
EDITORI recently took a similar length of time as Wald to complete a 60 page COREC form, for a study comparing two different approaches to the management of cancer pain.1 Wald may have been unduly harsh about the process and available support.
Perhaps I have been lucky, but I have had invaluable help from our trust's research and effectiveness department, based at the Bristol Royal Infirmary. Involving them at the protocol development stage undoubtedly facilitated this. I have also received useful (and money saving) advice from the Medicines and Healthcare Products Regulatory Agency and, like Wald, was able to apply for a doctors' and dentists' exemption, which was rolled over to a clinical trials authorisation on 1 May, thereby saving some £2000. Because other researchers were doing likewise (the agency's workload was quadrupled for that period; personal communication, 2004), this unsurprisingly resulted in some delay in issuing the
Colette M Reid, research fellow
Department of Palliative Medicine, Bristol Haematology and Oncology Centre, Bristol BS2 8ED colette.reid@bristol.ac.uk